MichaelHHuoMD

Orthopaedic Surgery • Dallas, TX

Hip & Knee Reconstructive Surgery

Professor, Orthopaedic Surgery, University of Texas Southwestern Medical Center, Southwestern Medical School

Join to view full profile

Dr. Huo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Huo's full profile

Already have an account?

Office
5323 Harry Hines Boulevard
Dallas, TX 75390
Phone+1 214-590-9818

Fax+1 214-590-6950

Education & Training

New York Presbyterian Hospital (Columbia Campus)Residency, Orthopaedic Surgery, 1989 - 1990
Yale-New Haven Medical CenterResidency, Orthopaedic Surgery, 1986 - 1989
Yale-New Haven Medical CenterResidency, Surgery, 1984 - 1986
George Washington University School of Medicine and Health SciencesClass of 1984

Certifications & Licensure

TX State Medical License 1997 - 2025
MD State Medical License 1994 - 1998
CT State Medical License 1991 - 1994
American Board of Orthopaedic Surgery Orthopaedic Surgery

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

Genetics Informatics Trial (GIFT) of Warfarin to Prevent DVT Start of enrollment: 2011 Mar 01
Completed
Phase 3

Publications & Presentations

PubMed

487 citations
Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery.
Jeffrey S. Ginsberg, Bruce L. Davidson, Charles W. Francis, Richard J. Friedman, Michael H. Huo
The Journal of Arthroplasty. 2009-01-01
306 citations
Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*): A randomised, double-blind, non-inferiority trial
Bengt I. Eriksson, Ola E. Dahl, Michael H. Huo, Andreas A. Kurth, Stefan Hantel
Thrombosis and Haemostasis. 2011-01-12
129 citations
A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT).
Alexander G.G. Turpie, Kenneth A. Bauer, Bruce L. Davidson, William D. Fisher, Michael Gent
Thrombosis and Haemostasis. 2008-12-06

Press Mentions

DePuy Knee Replacement Failure Results in Lawsuit over Attune Implant DesignAugust 16th, 2018
Where Are We Now? Expanding AAHKS InternationallyAugust 17th, 2018